New Zealand's Pharmac has announced plans to deploy more of its recent funding boost under a deal with AstraZeneca. The deal will see medicines reimbursed for lung and breast cancer, RSV in infants, and chronic obstructive pulmonary disease.
Pharmac announces plan to deploy more of its recent funding boost
September 16, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
TGA approves first-of-a-kind medicine for early symptomatic Alzheimer’s disease
May 21, 2025 - - Latest News -
Examples are important as evidence of the problem, but be prepared to defend them
May 21, 2025 - - Latest News -
Trump administration invites companies to 'align' US pricing under MFN plan
May 21, 2025 - - Latest News -
NDIS minister restates the importance of 'nothing about us, without us!'
May 20, 2025 - - Latest News -
Industry alarm over the sudden pursuit of surprise uncertified claims
May 20, 2025 - - Latest News -
Medicines Australia sharpens post-election language on reform
May 20, 2025 - - Latest News -
Report highlights international confidence in Australian clinical trials
May 19, 2025 - - Latest News